ArticleACS applied materials & interfaces2025
Ultrasensitive and Tunable Achiral Metamaterial Substrates as Nanobiosensors for Enantiomer Detection.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circular Dichroism via Extrinsic Chirality in Achiral Plasmonic Nanohole Arrays.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Distinguishing the chirality of biomolecules is of fundamental importance in biophysics and pharmaceutics. Circular dichroism (CD) spectroscopy provides a noninvasive approach to distinguish right- and left-handed enantiomers and can offer valuable insight into the structure of the investigated molecules. However, the intrinsic CD signal of biomolecules is often weak and typically resides in the ultraviolet spectral range, for which optical components are costly. Therefore, a tunable platform that boosts the CD signal of analytes in the optimal spectral range for the desired application would be an ideal solution. We combine tilted plasmonic nanohole arrays with ultrathin photonic cavities in our metamaterial substrates to achieve very high CD signal enhancement. In this approach, the spectral region with a high CD signal can be tailored by the geometric parameters of the array and cavity. In a tilted geometry, achiral structures mimic chiral behavior, offering an interesting alternative to inherently chiral structures. Our work highlights the role of near-field optical chirality and of the chirality enhancement factor, χ, in boosting the CD signal. To combine plasmonic and photonic effects for CD enhancement, we integrate the nanohole array as a top layer in a metal-dielectric-metal cavity structure. This metamaterial design strongly amplifies the electromagnetic near field and, in particular, its asymmetry. From both experimental and numerical results, we obtain another 10-fold increase in the χ factor, leading to a 50-fold enhancement compared to the bare biolayer on glass. With our robust and intrinsically achiral plasmonic and photonic metamaterial structures, we introduce a versatile platform for enantiomer discrimination and nanobiosensing applications that allows for spectral tuning of the operational resonance band via the geometry of the lattice and cavity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.